XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Jul. 29, 2023
Jul. 30, 2022
Cash flows from operating activities    
Net income $ 27,926 $ 38,940
Adjustments to reconcile net income to cash provided by operating activities    
(Gain)/loss on disposal and impairment of assets 113 (4)
(Gain)/loss on sale of investments 307 30
Provision for doubtful accounts (405) 293
Depreciation and amortization 10,211 9,516
Amortization of right-of-use lease assets 17,265 18,845
Lease impairment/(settlement) (1,175) 0
Equity-based compensation expense 2,526 1,417
Change in deferred taxes 602 544
Change in receivables 14,769 25,098
Change in inventories 9,271 (25,954)
Change in other assets (2,820) (1,229)
Change in payables (8,565) 22,113
Change in lease liabilities (17,882) (19,256)
Change in other liabilities (26,230) (37,249)
Net cash provided by operating activities 25,913 33,104
Cash flows from investing activities    
Proceeds from disposals of assets 4,031 46
Capital expenditures (13,457) (20,999)
Purchases of investments (11,407) (2,176)
Proceeds from sales of investments 12,404 4,421
Acquisitions (4,250) (7,230)
Net cash used for investing activities (12,679) (25,938)
Cash flows from financing activities    
Payments on debt and finance lease liabilities (67) (31)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes (1,978) (1,703)
Repurchases of common stock (10,007) (5,004)
Dividends paid to shareholders (7,852) (7,097)
Net cash used for financing activities (19,904) (13,835)
Effect of exchange rate changes on cash and equivalents 242 (750)
Change in cash, cash equivalents and restricted cash (6,428) (7,419)
Cash, cash equivalents and restricted cash at beginning of period 346,678 248,856
Cash, cash equivalents and restricted cash at end of period 340,250 241,437
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 7,188 $ 7,130